Factors associated with progression free survival treated with lenvatinib.

التفاصيل البيبلوغرافية
العنوان: Factors associated with progression free survival treated with lenvatinib.
المؤلفون: Kenji Yamaoka (11965273), Kenichiro Kodama (8876240), Tomokazu Kawaoka (128666), Masanari Kosaka (11965276), Yusuke Johira (11965279), Yuki Shirane (11965282), Ryoichi Miura (11965285), Shigeki Yano (11965288), Serami Murakami (11965291), Kei Amioka (11965294), Kensuke Naruto (11965297), Yuwa Ando (11965300), Yumi Kosaka (11965303), Shinsuke Uchikawa (11032037), Takuro Uchida (756174), Hatsue Fujino (4348360), Takashi Nakahara (1677235), Eisuke Murakami (756173), Wataru Okamoto (6496550), Masami Yamauchi (8876237), Daiki Miki (128628), Michio Imamura (128656), Shoichi Takahashi (128660), Akiko Nagao (2637289), Kazuaki Chayama (128675), Hiroshi Aikata (128663)
سنة النشر: 2022
المجموعة: Smithsonian Institution: Digital Repository
مصطلحات موضوعية: Biotechnology, Evolutionary Biology, Cancer, Science Policy, Virology, Chemical Sciences not elsewhere classified, various clinical data, univariate analysis showed, multivariate analysis showed, h0r ], bioelectrical impedance analysis, 33 – 5, 32 – 7, 03 – 11, +eighty%22">xlink "> eighty, body composition assessment, 23 – 3, longer overall survival, advanced hepatocellular carcinoma, os ), progression, tbw ≤ 0, %22">xlink ">, hepatocellular carcinoma, body composition, progression survival, ≤ 0, advanced hcc, longer os
Time: 4
الوصف: Factors associated with progression free survival treated with lenvatinib.
نوع الوثيقة: dataset
اللغة: unknown
Relation: https://figshare.com/articles/dataset/Factors_associated_with_progression_free_survival_treated_with_lenvatinib_/18645160
DOI: 10.1371/journal.pone.0262675.t003
الاتاحة: https://doi.org/10.1371/journal.pone.0262675.t003
Rights: CC BY 4.0
رقم الانضمام: edsbas.DC60B47F
قاعدة البيانات: BASE
الوصف
DOI:10.1371/journal.pone.0262675.t003